BioAffinity Technologies Profit Margin

The latest profit margin for BIAF is -257.33% as of June 2026. That compares with -152.18% in the prior-year period — down 69.1% year over year. That is below the sector sector average of 21.36%. Investors often review this figure alongside BioAffinity Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, BIAF's profit margin moved from -152.18% to -257.33% — a 69.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioAffinity Technologies's valuation or profitability profile.

Against its sector companies, BIAF currently prints -257.33% for profit margin, while the sector average sits near 21.36%. That is roughly 1304.9% below the sector mean. Large gaps often invite a closer look at BioAffinity Technologies's growth, margins, and balance sheet.

Profit Margin shows how effectively BioAffinity Technologies converts resources into returns. At -257.33%, BIAF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -152.18% in the prior-year period — down 69.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BIAF's profit margin (-257.33%), review year-over-year change from -152.18%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.